Correction to “Retrospective analysis of anti-inflammatory therapies during the first wave of COVID-19 at a community hospital”

Table 1 Coronavirus disease 2019 patients admitted to intensive care unit characteristics of survivors and non-survivors

	Non-survivor (n = 167)	Survivors (n = 94)	P value	OR	95%CI
Age	72 (63-82)	65.5 (51-74)	< 0.001
Race (Caucasian)	125 (74.9)	57 (60.6)	0.016	1.9	1.12-3.3
BMI	29 (23.9, 34.7)	28.6 (24, 33)	0.49
Sex (male)	102 (61)	56 (60)	0.81	1.065	0.63-1.78
Diabetes	60 (35)	24 (26)	0.08	1.63	0.93-2.8
CHF	24 (15)	10 (11)	0.38	1.42	0.64-3.1
CAD	45 (27)	20 (21)	0.30	1.36	0.74-2.48
COPD	38 (23)	23 (25)	0.75	0.9	0.5-1.64
CKD	25 (15)	13 (14)	0.8	1.09	0.53-2.26
HTN	100 (60)	45 (48)	0.061	1.62	0.97-2.70
AKI	87 (52)	30 (32)	0.002	2.3	1.21-2.5
Mechanical ventilation	134 (80)	44 (47)	< 0.001	4.6	2.64-8
Hemodialysis	29(18)	10 (11)	0.13	1.8	0.83-3.8
Neutrophils × 109/L	7.4 (5-11.79)	7.8 4.4-12.9	0.92
Lymphocytes	0.7 (0.5, 1.2)	0.9 (0.6, 1.6)	0.011
Neutrophil/lymphocyte	10 (6, 18.5)	7.54 4.3-14.2	0.017
SCr (mg/dL)	1.2 (0.8-1.8)	1.1 (0.8, 0.8)	0.49
Plts (× 109/L)	202 (166-268)	232 (155-301)	0.27
Tbili (mg/dl)	0.5 (0.4, 0.8)	0.5 (0.4, 0.8)	0.65
SOFA admit	4 (3-7)	4 (2, 6)	0.095
PaO2/FIO2	190 (76, 285)	232 (123, 307)	0.039
PaO2	69 (55-86)	73 (59-96)	0.083
FIO2	0.44 (0.24-1)	0.36 (0.21-0.97)	0.12

OR: Odds ratio; CI: Confidence interval; CAD: Coronary artery disease; COPD: Chronic obstructive pulmonary disease; CKD: Chronic kidney disease; CHF: Congestive heart failure; AKI: Acute kidney injury; HD: Hemodialysis; tBili: Total bilirubin; Plts: Platelets INR: International normalized ratio; PaO2/FiO2: Partial pressure of oxygen/inspired concentration of oxygen ratio; SOFA: Sequential Organ Failure Assessment; BMI: Body mass index; SCr: Serum creatinine.